Genomic DNA nanoparticles rescue rhodopsin-associated retinitis pigmentosa phenotype
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Mutations in the rhodopsin gene cause retinal degeneration and clinical phenotypes including retinitis pigmentosa (RP) and congenital stationary night blindness. Effective gene therapies have been difficult to develop, however, because generating precise levels of rhodopsin expression is critical; overexpression causes toxicity, and underexpression would result in incomplete rescue. Current gene delivery strategies routinely use cDNA‐based vectors for gene targeting; however, inclusion of noncoding components of genomic DNA (gDNA) such as introns may help promote more endogenous regulation of gene expression. Here we test the hypothesis that inclusion of genomic sequences from the rhodopsin gene can improve the efficacy of rhodopsin gene therapy in the rhodopsin knockout (RKO) mouse model of RP. We utilize our compacted DNA nanoparticles (NPs), which have the ability to transfer larger and more complex genetic constructs, to deliver murine rhodopsin cDNA or gDNA. We show functional and structural improvements in RKO eyes for up to 8 months after NP‐mediated gDNA but not cDNA delivery. Importantly, in addition to improvements in rod function, we observe significant preservation of cone function at time points when cones in the RKO model are degenerated. These results suggest that inclusion of native expression elements, such as introns, can significantly enhance gene expression and therapeutic efficacy and may become an essential option in the array of available gene delivery tools.— Han, Z., Banworth, M. J., Makkia, R., Conley, S. M., Al‐Ubaidi, M. R., Cooper, M. J., Naash, M. I. Genomic DNA nanoparticles rescue rhodopsin‐associated retinitis pigmentosa phenotype. FASEB J. 29, 2535‐2544 (2015). www.fasebj.org
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Single-molecule DNA nanoparticles compacted by polyethylene glycol (PEG)-substituted lysine peptides (CK30-PEG) have been used to carry payloads up to 20 kb in size,82,83 with several groups demonstrating their safety in BALB/c mice and rds+/− Rho-/- or Abca4-/- mouse models of retinal degeneration.82–86”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [85]
In the citing paper
“These plasmid modifications have been shown to be effective in gene delivery in Rpe65−/−, Abca4−/− and Rhodopsin−/− [41,45,46].”
From The Ocular Gene Delivery Landscape (2021) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Integrating mRNA Processing with Transcription
Proudfoot, N. J., Furger, A., & Dye, M. J. (2002) · Cell · doi:10.1016/s0092-8674(02)00617-7 · Cited by 1,082 · cited 1×
“Splicing and polyadenylation have been shown to influence each other (reviewed elsewhere) (37).”
BackgroundIntrons increase transcriptional efficiency in transgenic mice.
Brinster, R. L., Allen, J. M., Behringer, R. R., Gelinas, R. E., & Palmiter, R. D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.3.836 · Cited by 722
A quantitative analysis of intron effects on mammalian gene expression
NOTT, A., MEISLIN, S. H., & MOORE, M. J. (2003) · RNA · doi:10.1261/rna.5250403 · Cited by 417 · cited 3×
“Introns have been shown to promote improved gene expression by affecting transcription, polyadenylation, and nuclear export as well as translation (14, 20).”
BackgroundNott, A., Le Hir, H., & Moore, M. J. (2004) · Genes & Development · doi:10.1101/gad.1163204 · Cited by 410 · cited 1×
“Importantly, this translational benefit could be recapitulated by artificially attaching several EJC components to an intron-less expression construct (36).”
BackgroundEfficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus
Flannery, J. G., Zolotukhin, S., Vaquero, M. I., LaVail, M. M., Muzyczka, N., & Hauswirth, W. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6916 · Cited by 407
Morphological, physiological, and biochemical changes in rhodopsin knockout mice
Lem, J., Krasnoperova, N. V., Calvert, P. D., Kosaras, B., Cameron, D. A., Nicolò, M., Makino, C. L., & Sidman, R. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.2.736 · Cited by 395 · cited 5×
“The predominant gene replacement strategy (both for rhodopsin andothergenes)utilizes cDNA(7, 8), buthavingadelivery strategy that yields properly regulated gene expression levels is especially critical because overexpression of rhodopsin is detrimental to rods (9, 10) and underexpression will yield incomplete rescue (…”
BackgroundResultInfluentialJacobson, S. G., Acland, G. M., Aguirre, G. D., Aleman, T. S., Schwartz, S. B., Cideciyan, A. V., Zeiss, C. J., Komaromy, A. M., Kaushal, S., Roman, A. J., et al. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.03.005 · Cited by 224 · cited 1×
“The predominant gene replacement strategy (both for rhodopsin andothergenes)utilizes cDNA(7, 8), buthavingadelivery strategy that yields properly regulated gene expression levels is especially critical because overexpression of rhodopsin is detrimental to rods (9, 10) and underexpression will yield incomplete rescue (…”
BackgroundDrosophila Y14 shuttles to the posterior of the oocyte and is required for oskar mRNA transport
Hachet, O., & Ephrussi, A. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00508-5 · Cited by 212 · cited 1×
“Several components of this complex remain attached to the transcript after splicing has completed and have been shown to promote export of the transcript to the cytoplasm in multiple systems as well as promote proper localization of mRNAsonce in the cytoplasm inDrosophila (35).”
BackgroundPiechaczek, C., Fetzer, C., Baiker, A., Bode, J., & Lipps, H. J. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.2.426 · Cited by 210
Efficient Non-Viral Ocular Gene Transfer with Compacted DNA Nanoparticles
Farjo, R., Skaggs, J., Quiambao, A. B., Cooper, M. J., & Naash, M. I. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000038 · Cited by 208 · cited 1×
“They efficiently transfect both photoreceptors and the retinal pigment epithelium(RPE) and canmediate persistent (up to 2 yr) gene expression (12, 24).”
BackgroundSelf-citationCritical association of ncRNA with introns
Rearick, D., Prakash, A., McSweeny, A., Shepard, S. S., Fedorova, L., & Fedorov, A. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1080 · Cited by 204 · cited 6×
“To assess the transcripts produced from the NPs, Northernblots onRNAs from treatedeyeswereperformed at postinjection (PI) 1 mo using a-[32P] rhodopsin cDNA as a probe (all methodological details can be found in the RHODOPSIN NANOPARTICLES FOR GENE THERAPY 2537 supporting information).”
BackgroundInfluentialChromatin loops are selectively anchored using scaffold/matrix-attachment regions
Heng, H. H. Q., Goetze, S., Ye, C. J., Liu, G., Stevens, J. B., Bremer, S. W., Wykes, S. M., Bode, J., & Krawetz, S. A. (2004) · Journal of Cell Science · doi:10.1242/jcs.00976 · Cited by 204 · cited 1×
“Although they lack distinct sequence motifs, S/MARs contain ;70% AT-rich regions (38), which have a high affinity for the nuclear matrix (39).”
BackgroundNuclear history of a pre-mRNA determines the translational activity of cytoplasmic mRNA
Matsumoto, K., Wassarman, K. M., & Wolffe, A. P. (1998) · The EMBO Journal · doi:10.1093/emboj/17.7.2107 · Cited by 203 · cited 3×
“Some work has shown, however, that inclusion of merely some (or one) intron, usually in the 59 rather than 39 position, can confer these regulatory benefits (20), so it may not be necessary to include all genomic material to promote improved gene expression (compared with cDNA).”
BackgroundBode, J., Benham, C., Knopp, A., & Mielke, C. (2000) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v10.i1.90 · Cited by 202 · cited 1×
“When located directly downstream of the expression cassette, S/MARs can help promote transcription (40, 41), in part thought to be due to localization of the DNA to an actively transcribed region of the nucleus and their ability to serve as an anchoring point for components needed for transcription.”
BackgroundNanoparticles of Compacted DNA Transfect Postmitotic Cells
Liu, G., Li, D., Pasumarthy, M. K., Kowalczyk, T. H., Gedeon, C. R., Hyatt, S. L., Payne, J. M., Miller, T. J., Brunovskis, P., Fink, T. L., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305776200 · Cited by 190 · cited 1×
“3 mg/ml of DNA), NPs underwent a standard panel of quality control tests including turbidity and saline sedimentation analyses (colloidal stability), transmission electron microscopy (NP size and shape), serum stability test (protection of DNA from nucleases), endotoxin measurements, and gel analysis (DNA integrity) a…”
MethodSelf-citationSplicing as a requirement for biogenesis of functional 16S mRNA of simian virus 40.
Gruss, P., Lai, C. J., Dhar, R., & Khoury, G. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4317 · Cited by 178
The relationship between opsin overexpression and photoreceptor degeneration.
Tan, E., Wang, Q., Quiambao, A. B., Xu, X., Qtaishat, N. M., Peachey, N. S., Lem, J., Fliesler, S. J., Pepperberg, D. R., Naash, M. I., et al. (2001) · PubMed · Cited by 173
Self-citationRNA Interference–Mediated Suppression and Replacement of Human Rhodopsin In Vivo
O’Reilly, M., Palfi, A., Chadderton, N., Millington-Ward, S., Ader, M., Cronin, T., Tuohy, T., Auricchio, A., Hildinger, M., Tivnan, A., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519025 · Cited by 173
Transfection of airway epithelium by stable PEGylated poly-l-lysine DNA nanoparticles in vivo
Ziady, A.-G., Gedeon, C. R., Miller, T., Quan, W., Payne, J. M., Hyatt, S. L., Fink, T. L., Muhammad, O., Oette, S., Kowalczyk, T., et al. (2003) · Molecular Therapy · doi:10.1016/j.ymthe.2003.07.007 · Cited by 165 · cited 1×
“DNANPswere formulatedas describedpreviously (23, 32).”
Self-citationRhodopsin Signaling and Organization in Heterozygote Rhodopsin Knockout Mice
Liang, Y., Fotiadis, D., Maeda, T., Maeda, A., Modzelewska, A., Filipek, S., Saperstein, D. A., Engel, A., & Palczewski, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408362200 · Cited by 157 · cited 1×
“It is also consistent with the phenotype in the rhodopsin heterozygote mouse; though it does not exhibit normal ERG function, the ERG responses are reduced by only a small amount at early ages (11, 42).”
ResultDNA nanoparticle-mediated ABCA4 delivery rescues Stargardt dystrophy in mice
Han, Z., Conley, S. M., Makkia, R. S., Cooper, M. J., & Naash, M. I. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64833 · Cited by 150 · cited 10×
“Western blotting was performed using standard protocols as previously described (22, 29).”
BackgroundMethodSelf-citationMillington-Ward, S., Chadderton, N., O'Reilly, M., Palfi, A., Goldmann, T., Kilty, C., Humphries, M., Wolfrum, U., Bennett, J., Humphries, P., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2010.293 · Cited by 141
Amado, D., Mingozzi, F., Hui, D., Bennicelli, J. L., Wei, Z., Chen, Y., Bote, E., Grant, R. L., Golden, J. A., Narfstrom, K., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000659 · Cited by 140
Fink, T. L., Klepcyk, P. J., Oette, S. M., Gedeon, C. R., Hyatt, S. L., Kowalczyk, T. H., Moen, R. C., & Cooper, M. J. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302761 · Cited by 139 · cited 3×
“DNANPswere formulatedas describedpreviously (23, 32).”
BackgroundMethodSelf-citationChadderton, N., Millington-Ward, S., Palfi, A., O'Reilly, M., Tuohy, G., Humphries, M. M., Li, T., Humphries, P., Kenna, P. F., & Farrar, G. J. (2009) · Molecular Therapy · doi:10.1038/mt.2008.301 · Cited by 124
Cai, X., Conley, S. M., Nash, Z., Fliesler, S. J., Cooper, M. J., & Naash, M. I. (2010) · The FASEB Journal · doi:10.1096/fj.09-139147 · Cited by 120 · cited 5×
“Subretinal injections were performed at postnatal day 3, as previously described (21).”
BackgroundMethodSelf-citationDesigning Nonviral Vectors for Efficient Gene Transfer and Long-Term Gene Expression
Jackson, D. A., Juranek, S., & Lipps, H. J. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.03.026 · Cited by 105 · cited 1×
“Although they lack distinct sequence motifs, S/MARs contain ;70% AT-rich regions (38), which have a high affinity for the nuclear matrix (39).”
BackgroundMouse opsin. Gene structure and molecular basis of multiple transcripts
Al‐Ubaidi, M. R., Pittler, S. J., Champagne, M. S., Triantafyllos, J. T., McGinnis, J. F., & Baehr, W. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30539-2 · Cited by 101
Self-citationProspects for retinal gene replacement therapy
Smith, A. J., Bainbridge, J. W., & Ali, R. R. (2009) · Trends in Genetics · doi:10.1016/j.tig.2009.02.003 · Cited by 99
The Nature of Dominant Mutations of Rhodopsin and Implications for Gene Therapy
Wilson, J. H., & Wensel, T. G. (2003) · Molecular Neurobiology · doi:10.1385/mn:28:2:149 · Cited by 96 · cited 1×
“MUTATIONS IN THE GENE for the rod photopigment rhodopsin are a common cause of RP, a hereditary blinding disease for which there is no proven therapy (1).”
BackgroundStehle, I. M., Scinteie, M. F., Baiker, A. E., Jenke, A., & Lipps, H. J. (2003) · Chromosome Research · doi:10.1023/a:1024962308071 · Cited by 93 · cited 1×
“When located directly downstream of the expression cassette, S/MARs can help promote transcription (40, 41), in part thought to be due to localization of the DNA to an actively transcribed region of the nucleus and their ability to serve as an anchoring point for components needed for transcription.”
BackgroundOverexpression of Rhodopsin Alters the Structure and Photoresponse of Rod Photoreceptors
Wen, X., Shen, L., Brush, R. S., Michaud, N. A., Al‐Ubaidi, M. R., Gurevich, V. V., Hamm, H. E., Lem, J., DiBenedetto, E., Anderson, R. E., et al. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2008.10.016 · Cited by 83 · cited 1×
“The predominant gene replacement strategy (both for rhodopsin andothergenes)utilizes cDNA(7, 8), buthavingadelivery strategy that yields properly regulated gene expression levels is especially critical because overexpression of rhodopsin is detrimental to rods (9, 10) and underexpression will yield incomplete rescue (…”
BackgroundSelf-citationComparative Analysis of DNA Nanoparticles and AAVs for Ocular Gene Delivery
Han, Z., Conley, S. M., Makkia, R., Guo, J., Cooper, M. J., & Naash, M. I. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052189 · Cited by 82 · cited 4×
“Western blotting was performed using standard protocols as previously described (22, 29).”
BackgroundMethodSelf-citationKoirala, A., Makkia, R. S., Conley, S. M., Cooper, M. J., & Naash, M. I. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt013 · Cited by 75 · cited 4×
“Although we have shown that vectors delivered via CK30-PEG NPs continue generating excellent expression in the RPE for several years (12, 25), we have routinely observed decreased NP-mediated gene expression in photoreceptors over time (21, 22).”
BackgroundMethodSelf-citationGene therapy in the second eye of RPE65-deficient dogs improves retinal function
Annear, M. J., Bartoe, J. T., Barker, S. E., Smith, A. J., Curran, P. G., Bainbridge, J. W., Ali, R. R., & Petersen-Jones, S. M. (2011) · Gene Therapy · doi:10.1038/gt.2010.111 · Cited by 74
Yurek, D. M., Flectcher, A. M., Kowalczyk, T. H., Padegimas, L., & Cooper, M. J. (2009) · Cell Transplantation · doi:10.3727/096368909x12483162196881 · Cited by 73
Self-citationOcular Delivery of Compacted DNA-Nanoparticles Does Not Elicit Toxicity in the Mouse Retina
Ding, X.-Q., Quiambao, A. B., Fitzgerald, J. B., Cooper, M. J., Conley, S. M., & Naash, M. I. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007410 · Cited by 71 · cited 1×
“The nanoparticles are also safe and well tolerated in the eye after intravitreal and subretinal delivery; we observed no induction of systemic or local immune response (21, 27, 28) and no signs of ectopic expression in extraocular tissues such as the brain (29).”
BackgroundSelf-citationPalfi, A., Millington-Ward, S., Chadderton, N., O'Reilly, M., Goldmann, T., Humphries, M. M., Li, T., Wolfrum, U., Humphries, P., Kenna, P. F., et al. (2010) · Human Gene Therapy · doi:10.1089/hum.2009.119 · Cited by 56 · cited 1×
“The predominant gene replacement strategy (both for rhodopsin andothergenes)utilizes cDNA(7, 8), buthavingadelivery strategy that yields properly regulated gene expression levels is especially critical because overexpression of rhodopsin is detrimental to rods (9, 10) and underexpression will yield incomplete rescue (…”
BackgroundAlternative readings of the genetic code
Farabaugh, P. J. (1993) · Cell · doi:10.1016/0092-8674(93)90507-m · Cited by 55 · cited 1×
“Some introns have functions independent of the gene in which they reside, for example, they can function as exons for other genes (15, 16), or they can be processed into critical noncoding RNAs (17).”
BackgroundKoirala, A., Conley, S. M., Makkia, R., Liu, Z., Cooper, M. J., Sparrow, J. R., & Naash, M. I. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.08.299 · Cited by 47 · cited 2×
“Although we have shown that vectors delivered via CK30-PEG NPs continue generating excellent expression in the RPE for several years (12, 25), we have routinely observed decreased NP-mediated gene expression in photoreceptors over time (21, 22).”
BackgroundSelf-citationHan, Z., Koirala, A., Makkia, R., Cooper, M. J., & Naash, M. I. (2012) · Nanomedicine · doi:10.2217/nnm.11.158 · Cited by 41
Self-citationIntron-exon organization of the gene for the multifunctional animal fatty acid synthase.
Amy, C. M., Williams-Ahlf, B., Naggert, J. Κ., & Smith, S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.3.1105 · Cited by 35 · cited 1×
“Some introns have functions independent of the gene in which they reside, for example, they can function as exons for other genes (15, 16), or they can be processed into critical noncoding RNAs (17).”
BackgroundNicoud, M., Kong, J., Iqball, S., Kan, O., Naylor, S., Gouras, P., Allikmets, R., & Binley, K. (2007) · The Journal of Gene Medicine · doi:10.1002/jgm.1115 · Cited by 21
Cited by
Injectable hydrogels for ophthalmic applications
Wang, K., & Han, Z. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.10.031 · Cited by 155
“Meanwhile, the gene delivery using an injectable hydrogel has also been studied as a treatment for retinitis pigmentosa [9, 10].”
BackgroundMethodSelf-citationGene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions
Drag, S., Dotiwala, F., & Upadhyay, A. K. (2023) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.64.7.39 · Cited by 145
Let There Be Light: Gene and Cell Therapy for Blindness
Dalkara, D., Goureau, O., Marazova, K., & Sahel, J.-A. (2016) · Human Gene Therapy · doi:10.1089/hum.2015.147 · Cited by 129
Seeing the light after 25 Years of retinal gene therapy
Trapani, I., & Auricchio, A. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.06.006 · Cited by 124
Retinitis Pigmentosa: Progress and Perspective
Zhang, Q. (2016) · Asia-Pacific Journal of Ophthalmology · doi:10.1097/apo.0000000000000227 · Cited by 109
“Compared with cDNA, gene delivery with native genomic DNA has been shown to significantly enhance gene expression and therapeutic efficacy.(63) A phase 1 clinical trial of gene therapy has been reported for 6 patients with retinitis pigmentosa due to MERTK mutations.”
Background
Metadata
- Authors
- Han, Z., Banworth, M. J., Makkia, R., Conley, S. M., Al‐Ubaidi, M. R., Cooper, M. J., & Naash, M. I.
- Affiliations
- University of Oklahoma Health Sciences Center (US)
- Copernicus Therapeutics (United States) (US)
- Corresponding author
- Han, Zongchao
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2015-02-24
- Volume
- 29
- Issue
- 6
- Pages
- 2535-2544
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- PMC
- PMC4447225
- OpenAlex
- W2013410637
- Cited by
- 54
- References
- 43
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 2 · 2023: 6 · 2022: 6 · 2021: 8 · 2020: 2 · 2019: 3 · 2018: 5 · 2017: 7 · 2016: 3 · 2015: 5
- FWCI
- 2.89
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The FASEB Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (R21EY024059‐ZH, EY018656‐MIN, EY22778‐MIN, EY018137‐MRA)
- Oklahoma Center for the Advancement of Science and Technology
- Knights Templar Eye Foundation
- Carolina Center of Cancer Nanotechnology Excellence, University of North Carolina - Chapel Hill
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Keywords
- retinitis pigmentosa, rhodopsin, gene therapy, DNA nanoparticles, introns, retinal degeneration, rod photoreceptors, cone photoreceptors, gene expression regulation, congenital stationary night blindness
- MeSH terms
- Animals, Disease Models, Animal, DNA, Gene Expression Regulation, Humans, Introns, Phenotype, Retina, Retinitis Pigmentosa, Rhodopsin, Blotting, Western, Reproducibility of Results, Genetic Therapy, Gene Transfer Techniques, Mice, Knockout, Microscopy, Confocal, Reverse Transcriptase Polymerase Chain Reaction, Microscopy, Electron, Transmission, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.